BHVN
Biohaven Ltd.Healthcare$9.80
◆ Neutral
Mkt Cap: $1.47B|Float: 123.9M|SI: 17.7%|DTC: 9.9
Data as of market close Apr 2, 2026
IV Rank
48
IV Pctl
67%
HV 20d
72.4%
52W Range
$7-$24
ATR(14)
$0.57
Exp. Move
±13.5%
P/C Ratio
0.19
Earnings
May 11
GEX Positive
DEX Long
Net Put Premium
IV Moderate
Max Pain Below
Exp. Move Wide
Low Put/Call
BHVN Key Options Data
- IV Rank
- 48%
- Total GEX
- $0.00B
- Total DEX
- $1.5M
- Max Pain
- $9.00
- Expected Move
- ±13.5%
- Put/Call OI
- 0.19
- Net Premium
- $-0.3M
- Spot Price
- $9.80
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$1.32 | ±13.5% | $8.48 | $11.13 |
| 2026-05-15 | 43 | ±$2.67 | ±27.3% | $7.13 | $12.48 |
| 2026-07-17 | 106 | ±$4.55 | ±46.4% | $5.25 | $14.35 |
| 2026-10-16 | 197 | ±$3.20 | ±32.6% | $6.60 | $13.00 |
| 2026-12-18 | 260 | ±$6.85 | ±69.9% | $2.95 | $16.65 |
| 2027-01-15 | 288 | ±$7.62 | ±77.8% | $2.18 | $17.43 |
Explore BHVN options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.